ANDA 74370, held by Watson Labs. Glipizide.
As of Nov 16, 2026, ANDA 74370 (Glipizide), held by Watson Labs, was first approved by FDA on Nov 22, 1994, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 22, 1994 | Original application | Approved | None posted |
| Apr 5, 1995 | Supplement 1Manufacturing | Approved | None posted |
| Apr 5, 1995 | Supplement 2Manufacturing | Approved | None posted |
| Nov 22, 1994 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters